Social/professional role & identity |
Urologists and staff consider initiating trial conversation as their role while others also take part in the referring process. |
Honestly it would have to start with the physicians because that’s where patients are going to get their initial information about a trial. But nurses are going to talk to patients and answer questions. We need to know what’s going on with trials as well.
[Talking about trials] is really part of giving the patient their options and making them aware of all of their options including trials. That should first come from the physician.
|
Urology staff see their role in offering clinical trials. |
|
Urologists see their role in following and co-managing patients on trial. |
|
Urologists feel responsible for maintaining positive professional relationship with their patients after the referral |
Of course, we can always refer patients on to whoever it is that has that information but sometimes if you’ve developed a relationship with a patient as a physician or as a nurse and they trust you to give them information and they want to get it from you, they don’t want to call someone they don’t know and ask them
|
Beliefs of consequences |
Urologists with positive attitudes toward clinical trials were more likely to offer trials to their patients. |
I like clinical trials, and I think they are how we advance medicine…so I’m probably biased towards trying to get people signed up.
You don’t always have a good outcome for them (patients) and so I think it’s good to be able to give them options.
he (a patient)’s not going to make it. It would just be neat to have something to offer him.
|
Emotion |
Urologists’ emotion, mainly fear, influence their decision to offer trials. |
I think nationwide there’s a perception that they’re going to lose the patient.if they sign up on a clinical trial…
We’re all human, I don’t want to be embarrassed, so I don’t want to bring up a topic and not know all the answers about it. So that’s probably one of the things I’m probably a little reluctant to talk to them about clinical trials, because I don’t know how the randomization is going to go, and I can’t answer all their questions…
|